{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:09:20Z","timestamp":1764688160032,"version":"build-2065373602"},"reference-count":106,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background and aim of this review: The ongoing opioid epidemic underscores the urgent need for innovative pharmacological and behavioral interventions to mitigate the impact of opioid use disorder (OUD). This review aims to explore theoretical overlaps between the neurobiological mechanisms underlying OUD development and the pharmacodynamic profile of methylphenidate (MPH). Particular attention is given to the potential shared molecular targets, safety considerations, and therapeutic implications of MPH use in this clinical context. Main finding: In the development of opioid dependence, the negative reinforcement of the dopaminergic transmission of the mesocorticolimbic pathway induced by the supraspinal action of opioid receptor agonists plays a major role. The induced state of hypodopaminergic and hyperadrenergic modulates the underlying disease process by affecting cognitive control, affective regulation, and motivational drive. MPH, acting as a dopamine reuptake inhibitor and modulator of vesicular monoamine transporter 2 (VMAT-2), increases extracellular dopamine availability and enhances dopaminergic signaling, suggesting potential utility in restoring dopaminergic tone in OUD. Additionally, MPH has shown efficacy in hypoactive delirium in patients with terminal cancer, improving both cognitive function and psychomotor drive. Conclusions and future perspectives: There appear to be converging neurobiological mechanisms between the action of MPH and the pathophysiology of OUD, particularly within the dopaminergic system. However, well-designed clinical trials are essential to identify the patient subgroups that may benefit from adjunctive MPH treatment, to evaluate its efficacy in this setting, and to assess the long-term safety and risk profile of stimulant use in individuals with OUD.<\/jats:p>","DOI":"10.3390\/brainsci15080850","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T15:30:52Z","timestamp":1754667052000},"page":"850","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methylphenidate as a Novel Adjunct in Opioid-Taking Patients: Insights into Dopaminergic Neuroadaptation and Hypoactive Delirium"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1776-9842","authenticated-orcid":false,"given":"Nikodem","family":"\u015awiderski","sequence":"first","affiliation":[{"name":"Student Scientific Organisation of Department and Clinic of Adult Psychiatry, Faculty of Medical Sciences, Medical University of Silesia, Ziolowa 45, 40-635 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-6745","authenticated-orcid":false,"given":"Patryk","family":"Rodek","sequence":"additional","affiliation":[{"name":"Department and Clinic of Adult Psychiatry, Faculty of Medical Sciences, Medical University of Silesia, Ziolowa 45, 40-635 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Kucia","sequence":"additional","affiliation":[{"name":"Department and Clinic of Adult Psychiatry, Faculty of Medical Sciences, Medical University of Silesia, Ziolowa 45, 40-635 Katowice, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/20494637231160684","article-title":"Is England Facing an Opioid Epidemic?","volume":"17","author":"Roberts","year":"2023","journal-title":"Br. J. Pain"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to Opioids in Chronic Pain Patients: A Literature Review","volume":"11","year":"2007","journal-title":"Eur. J. Pain"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17425255.2020.1721458","article-title":"Pharmacokinetic and Pharmacodynamic Considerations in Developing a Response to the Opioid Epidemic","volume":"16","author":"Balyan","year":"2020","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bph.16043","article-title":"Opioid Research in the Time of the Opioid Crisis","volume":"180","author":"Traynor","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","volume":"9","author":"Kampman","year":"2015","journal-title":"J. Addict. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","article-title":"A Brief History of the Opioid Epidemic and Strategies for Pain Medicine","volume":"7","author":"Jones","year":"2018","journal-title":"Pain Ther."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hoffman, K.A., Ponce Terashima, J., and McCarty, D. (2019). Opioid Use Disorder and Treatment: Challenges and Opportunities. BMC Health Serv. Res., 19.","DOI":"10.1186\/s12913-019-4751-4"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for Opioid Use Disorder: Population Estimates\u2014United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"108350","DOI":"10.1016\/j.drugalcdep.2020.108350","article-title":"The Economic Burden of Opioid Use Disorder and Fatal Opioid Overdose in the United States, 2017","volume":"218","author":"Florence","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"ref_10","unstructured":"Drug-Induced Deaths\u2014The Current Situation in Europe (European Drug Report 2025). Available online: https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2025\/drug-induced-deaths_en."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/bph.12673","article-title":"\u03b2-Arrestin-2 Knockout Prevents Development of Cellular \u039c-opioid Receptor Tolerance but Does Not Affect Opioid-withdrawal-related Adaptations in Single PAG Neurons","volume":"172","author":"Connor","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2165\/00003088-200443130-00004","article-title":"Clinical Pharmacology of Tramadol","volume":"43","author":"Grond","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1080\/15563650.2022.2124919","article-title":"Factors Associated with Seizure in Tramadol Overdose: A 12-Year Retrospective Study in Hong Kong","volume":"60","author":"Cheng","year":"2022","journal-title":"Clin. Toxicol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2147\/DDDT.S402362","article-title":"Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings","volume":"17","author":"Alshehri","year":"2023","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s40265-021-01515-z","article-title":"Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients","volume":"81","author":"Roulet","year":"2021","journal-title":"Drugs"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1080\/03007995.2022.2112874","article-title":"Development of a Potential Opioid Misuse Measure from Administrative Dispensing Data and Contrasting Opioid Misuse among Individuals on Long-Term Tramadol, Long-Term Short-Acting Hydrocodone or Long-Term Short-Acting Oxycodone Therapy in Arkansas","volume":"38","author":"Acharya","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0091-3057(98)00123-3","article-title":"Antinociception, Tolerance, and Physical Dependence Comparison Between Morphine and Tramadol","volume":"61","author":"Miranda","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1382.e1","DOI":"10.1016\/j.amjmed.2018.04.025","article-title":"Tramadol: Understanding the Risk of Serotonin Syndrome and Seizures","volume":"131","author":"Hassamal","year":"2018","journal-title":"Am. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of Novel Synthetic Opioids: A Deadly New Trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addict. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Lovrecic, B., Lovrecic, M., Gabrovec, B., Carli, M., Pacini, M., Maremmani, A.G.I., and Maremmani, I. (2019). Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16020177"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.1073\/pnas.1214605109","article-title":"Pain Relief Produces Negative Reinforcement through Activation of Mesolimbic Reward\u2013Valuation Circuitry","volume":"109","author":"Navratilova","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.neuroscience.2008.04.063","article-title":"Cocaine Reward and Hyperactivity in the Rat: Sites of Mu Opioid Receptor Modulation","volume":"154","author":"Soderman","year":"2008","journal-title":"Neuroscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00115550-200705000-00012","article-title":"Understanding How Opioids Contribute to Reward and Analgesia","volume":"32","author":"Fields","year":"2007","journal-title":"Reg. Anesth. Pain Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0091-3057(84)90224-7","article-title":"Endorphinergic Modulation of Neural Reward Systems Indicated by Behavioral Changes","volume":"21","author":"Dum","year":"1984","journal-title":"Pharmacol. Biochem. Behav."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41586-024-07440-x","article-title":"Distinct \u039c-Opioid Ensembles Trigger Positive and Negative Fentanyl Reinforcement","volume":"630","author":"Chaudun","year":"2024","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1042\/bst0200449","article-title":"Regulation of Brain Neurotransmitter Release and of Adenylate Cyclase Activity by Opioid Receptors","volume":"20","author":"Schoffelmeer","year":"1992","journal-title":"Biochem. Soc. Trans."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.pmbts.2015.10.005","article-title":"Molecular Changes in Opioid Addiction: The Role of Adenylyl Cyclase and cAMP\/PKA System","volume":"Volume 137","author":"Chan","year":"2016","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s13311-020-00927-1","article-title":"Neuronal Adenylyl Cyclase Targeting Central Plasticity for the Treatment of Chronic Pain","volume":"17","author":"Li","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement","volume":"87","author":"Koob","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The Role of D2-Autoreceptors in Regulating Dopamine Neuron Activity and Transmission","volume":"282","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"107583","DOI":"10.1016\/j.pharmthera.2020.107583","article-title":"Dopamine D2 Autoreceptor Interactome: Targeting the Receptor Complex as a Strategy for Treatment of Substance Use Disorder","volume":"213","author":"Chen","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1523\/JNEUROSCI.22-08-03293.2002","article-title":"Changes in Extracellular Dopamine Induced by Morphine and Cocaine: Crucial Control by D2 Receptors","volume":"22","author":"Usiello","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874473710902020195","article-title":"Phasic Dopamine Release in Appetitive Behaviors and Drug Addiction","volume":"2","author":"Wanat","year":"2009","journal-title":"Curr. Drug Abus. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1360-0443.95.8s2.19.x","article-title":"The Psychology and Neurobiology of Addiction: An Incentive\u2013Sensitization View","volume":"95","author":"Robinson","year":"2000","journal-title":"Addiction"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0896-6273(00)80374-8","article-title":"Acute Effects of Cocaine on Human Brain Activity and Emotion","volume":"19","author":"Breiter","year":"1997","journal-title":"Neuron"},{"key":"ref_36","first-page":"5548623","article-title":"Cognitive Impairment in Opium Use Disorder","volume":"2021","author":"Shadloo","year":"2021","journal-title":"Behav. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jpsychires.2023.05.018","article-title":"The Impact of Opioid-Stimulant Co-Use on Tonic and Cue-Induced Craving","volume":"164","author":"Hochheimer","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1521-0391.2014.12129.x","article-title":"Cue-induced Craving in Dependence upon Prescription Opioids and Heroin","volume":"23","author":"McHugh","year":"2014","journal-title":"Am. J. Addict."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.156.1.11","article-title":"Limbic Activation During Cue-Induced Cocaine Craving","volume":"156","author":"Childress","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/add.15635","article-title":"New Means, New Measures: Assessing Prescription Drug-seeking Indicators over 10 Years of the Opioid Epidemic","volume":"117","author":"Perry","year":"2022","journal-title":"Addiction"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/s41467-022-33843-3","article-title":"Reward and Aversion Processing by Input-Defined Parallel Nucleus Accumbens Circuits in Mice","volume":"13","author":"Zhou","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s002130050267","article-title":"Chiral Drugs: Comparison of the Pharmacokinetics of [ 11 C] d-Threo and l-Threo -Methylphenidate in the Human and Baboon Brain","volume":"131","author":"Ding","year":"1997","journal-title":"Psychopharmacology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00023210-200620090-00002","article-title":"Methylphenidate and Its Isomers: Their Role in the Treatment of Attention-Deficit Hyperactivity Disorder Using a Transdermal Delivery System","volume":"20","author":"Heal","year":"2006","journal-title":"CNS Drugs"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1080\/17512433.2020.1796636","article-title":"An Update on the Clinical Pharmacology of Methylphenidate: Therapeutic Efficacy, Abuse Potential and Future Considerations","volume":"13","author":"Shellenberg","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/FBP.0b013e3280143226","article-title":"Methylphenidate and Its Ethanol Transesterification Metabolite Ethylphenidate: Brain Disposition, Monoamine Transporters and Motor Activity","volume":"18","author":"Williard","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2007.05.044","article-title":"Therapeutic Doses of Amphetamine and Methylphenidate Selectively Redistribute the Vesicular Monoamine Transporter-2","volume":"571","author":"Riddle","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0041-008X(89)90309-8","article-title":"Methylphenidate and Pemoline Do Not Cause Depletion of Rat Brain Monoamine Markers Similar to That Observed with Methamphetamine","volume":"100","author":"Zaczek","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1471-4159.2005.03506.x","article-title":"Immunoisolation of Two Synaptic Vesicle Pools from Synaptosomes: A Proteomics Analysis","volume":"95","author":"Morciano","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejphar.2003.08.077","article-title":"Impact of Psychostimulants on Vesicular Monoamine Transporter Function","volume":"479","author":"Fleckenstein","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1176\/ajp.155.10.1325","article-title":"Dopamine Transporter Occupancies in the Human Brain Induced by Therapeutic Doses of Oral Methylphenidate","volume":"155","author":"Volkow","year":"1998","journal-title":"Am. J. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/sj.bjp.0706428","article-title":"Neurotransmitter Transporters and Their Impact on the Development of Psychopharmacology","volume":"147","author":"Iversen","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1471-4159.1985.tb05524.x","article-title":"[3H]Threo-(\u00b1)-Methylphenidate Binding to 3,4-Dihydroxyphenylethylamine Uptake Sites in Corpus Striatum: Correlation with the Stimulant Properties of Ritalinic Acid Esters","volume":"45","author":"Schweri","year":"1985","journal-title":"J. Neurochem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0006-8993(90)91719-W","article-title":"Comparison of the Effects of Cocaine and Other Inhibitors of Dopamine Uptake in Rat Striatum, Nucleus Accumbens, Olfactory Tubercle, and Medial Prefrontal Cortex","volume":"520","author":"Izenwasser","year":"1990","journal-title":"Brain Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"590","DOI":"10.2174\/1381612822666151124235816","article-title":"Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects","volume":"22","author":"Golmirzaei","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e13387","DOI":"10.1111\/jsr.13387","article-title":"European Guideline and Expert Statements on the Management of Narcolepsy in Adults and Children","volume":"30","author":"Bassetti","year":"2021","journal-title":"J. Sleep Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3810\/pgm.2011.09.2457","article-title":"Exploring the Impact of Once-Daily OROS\u00ae Methylphenidate (MPH) on Symptoms and Quality of Life in Children and Adolescents with ADHD Transitioning from Immediate-Release MPH","volume":"123","author":"Kordon","year":"2011","journal-title":"Postgrad. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00213-020-05691-w","article-title":"Cognitive Enhancement Effects of Stimulants: A Randomized Controlled Trial Testing Methylphenidate, Modafinil, and Caffeine","volume":"238","author":"Repantis","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1176\/appi.ajp.2014.14070889","article-title":"Citalopram, Methylphenidate, or Their Combination in Geriatric Depression: A Randomized, Double-Blind, Placebo-Controlled Trial","volume":"172","author":"Lavretsky","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/pon.4220","article-title":"Randomized, Double-blind, Placebo-controlled Study of Methylphenidate for the Treatment of Depression in SSRI-treated Cancer Patients Receiving Palliative Care","volume":"26","author":"Sullivan","year":"2017","journal-title":"Psycho-Oncology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jpainsymman.2020.05.023","article-title":"Methylphenidate as Needed for Fatigue in Patients With Advanced Cancer. A Prospective, Double-Blind, and Placebo-Controlled Study","volume":"60","author":"Pedersen","year":"2020","journal-title":"J. Pain Symptom Manag."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PPO.0000000000000018","article-title":"A Randomized, Double-Blind, 2-Period, Placebo-Controlled Crossover Trial of a Sustained-Release Methylphenidate in the Treatment of Fatigue in Cancer Patients","volume":"20","author":"Escalante","year":"2014","journal-title":"Cancer J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuroimage.2006.07.014","article-title":"Methylphenidate Modulates Cerebral Post-Stroke Reorganization","volume":"33","author":"Tardy","year":"2006","journal-title":"NeuroImage"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0269881108089809","article-title":"Safety of Therapeutic Methylphenidate in Adults: A Systematic Review of the Evidence","volume":"23","author":"Godfrey","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"ref_64","first-page":"CD009885","article-title":"Methylphenidate for Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)","volume":"2023","author":"Storm","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_65","first-page":"h5203","article-title":"Methylphenidate for Attention-Deficit\/Hyperactivity Disorder in Children and Adolescents: Cochrane Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomised Clinical Trials","volume":"351","author":"Krogh","year":"2015","journal-title":"BMJ"},{"key":"ref_66","first-page":"CD012069","article-title":"Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents\u2014Assessment of Adverse Events in Non-Randomised Studies","volume":"5","author":"Pedersen","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_67","first-page":"e55604","article-title":"Methylphenidate-Induced Non-Ischemic Heart Failure With Reduced Ejection Fraction and Mild Pulmonary Hypertension","volume":"16","author":"Ugwendum","year":"2024","journal-title":"Cureus"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"313.e1","DOI":"10.1016\/j.ajem.2014.08.004","article-title":"Intravenous Methylphenidate: An Unusual Way to Provoke ST-Elevation Myocardial Infarction","volume":"33","author":"Hay","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e6980","DOI":"10.5867\/medwave.2017.05.6980","article-title":"Brief Psychosis Induced by Methylphenidate in a Child with Attention Deficit Disorder: A Case Report and Literature Review","volume":"17","author":"Arancibia","year":"2017","journal-title":"Medwave"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Bie\u015b, R., Fojcik, J., Warchala, A., Tr\u0119dzbor, B., Krysta, K., Piekarska-Bugiel, K., and Krzystanek, M. (2023). The Risk of Methylphenidate Pharmacotherapy for Adults with ADHD. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091292"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3810\/pgm.2014.09.2801","article-title":"The Potential for Misuse and Abuse of Medications in ADHD: A Review","volume":"126","author":"Clemow","year":"2014","journal-title":"Postgrad. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","article-title":"Cellular and Molecular Mechanisms of Drug Dependence","volume":"242","author":"Koob","year":"1988","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","article-title":"Addiction and the Brain Antireward System","volume":"59","author":"Koob","year":"2008","journal-title":"Annu. Rev. Psychol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/pr.112.005942","article-title":"Regulation of \u039c-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance","volume":"65","author":"Williams","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.tips.2016.08.002","article-title":"Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation","volume":"37","author":"Cahill","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Diana, M. (2011). The Dopamine Hypothesis of Drug Addiction and Its Potential Therapeutic Value. Front. Psychiatry, 2.","DOI":"10.3389\/fpsyt.2011.00064"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00018-020-03595-8","article-title":"Signaling Mechanisms of \u03bc-Opioid Receptor (MOR) in the Hippocampus: Disinhibition versus Astrocytic Glutamate Regulation","volume":"78","author":"Nam","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"102964","DOI":"10.1016\/j.ajp.2021.102964","article-title":"Serum Corticotrophin Releasing Factor (CRF) and Its Correlation with Stress and Craving in Detoxified Opioid-Dependent Subjects","volume":"68","author":"Chatterjee","year":"2022","journal-title":"Asian J. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1016\/j.neuron.2022.09.024","article-title":"Modulation of 5-HT Release by Dynorphin Mediates Social Deficits during Opioid Withdrawal","volume":"110","author":"Pomrenze","year":"2022","journal-title":"Neuron"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/ajad.12607","article-title":"Increased Habenular Connectivity in Opioid Users Is Associated with an A5 Subunit Nicotinic Receptor Genetic Variant","volume":"26","author":"Curtis","year":"2017","journal-title":"Am. J. Addict."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09540261.2018.1524373","article-title":"Pharmacotherapy for Opioid Addiction in Community Corrections","volume":"30","author":"Schwartz","year":"2018","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"j2047","DOI":"10.1136\/bmj.j2047","article-title":"Hypoactive Delirium","volume":"357","author":"Hosker","year":"2017","journal-title":"BMJ"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/09540260802675460","article-title":"Motor Subtypes of Delirium: Past, Present and Future","volume":"21","author":"Meagher","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jocn.13155","article-title":"Delirium Recall\u2014An Integrative Review","volume":"25","author":"Fuller","year":"2016","journal-title":"J. Clin. Nurs."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Darbyshire, J.L., Greig, P.R., Vollam, S., Young, J.D., and Hinton, L. (2016). \u201cI Can Remember Sort of Vivid People\u2026but to Me They Were Plasticine.\u201d Delusions on the Intensive Care Unit: What Do Patients Think Is Going On?. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0160296"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/PSY.0000000000000239","article-title":"Differential Associations Between Delirium and Mortality According to Delirium Subtype and Age: A Prospective Cohort Study","volume":"77","author":"Kim","year":"2015","journal-title":"Psychosom. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0019-5545.31604","article-title":"Is This \u2032complicated\u2032 Opioid Withdrawal?","volume":"48","author":"Parkar","year":"2006","journal-title":"Indian J. Psychiatry"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.psym.2017.12.002","article-title":"A Case of Delirium and Rhabdomyolysis in Severe Iatrogenic Opioid Withdrawal","volume":"59","author":"Hanna","year":"2018","journal-title":"Psychosomatics"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1176\/jnp.23.4.jnpe37","article-title":"Opioid Withdrawal Delirium","volume":"23","author":"Aggarwal","year":"2011","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/0253-7176.217027","article-title":"Opioid Withdrawal Presenting as Delirium and Role of Buprenorphine: A Case Series","volume":"39","author":"Das","year":"2017","journal-title":"Indian J. Psychol. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.mehy.2011.03.048","article-title":"Hypothesis for the Pathophysiology of Delirium: Role of Baseline Brain Network Connectivity and Changes in Inhibitory Tone","volume":"77","author":"Sanders","year":"2011","journal-title":"Med. Hypothes."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1176\/appi.ajp.2012.11060976","article-title":"Neural Network Functional Connectivity During and After an Episode of Delirium","volume":"169","author":"Choi","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.271.5248.512","article-title":"Activation by Attention of the Human Reticular Formation and Thalamic Intralaminar Nuclei","volume":"271","author":"Kinomura","year":"1996","journal-title":"Science"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.mehy.2004.08.007","article-title":"Psychotogenic Drugs and Delirium Pathogenesis: The Central Role of the Thalamus","volume":"64","author":"Gaudreau","year":"2005","journal-title":"Med. Hypothes."},{"key":"ref_95","first-page":"100","article-title":"Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: A prospective clinical study","volume":"30","author":"Gagnon","year":"2005","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_96","first-page":"134","article-title":"Successful Palliation of Hypoactive Delirium Due to Multi-Organ Failure by Oral Methylphenidate","volume":"8","author":"Morita","year":"2000","journal-title":"Support. Care Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.biopsych.2010.06.023","article-title":"Psychostimulants as Cognitive Enhancers: The Prefrontal Cortex, Catecholamines, and Attention-Deficit\/Hyperactivity Disorder","volume":"69","author":"Berridge","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4088\/JCP.12r08287","article-title":"Effect of Psychostimulants on Brain Structure and Function in ADHD: A Qualitative Literature Review of Magnetic Resonance Imaging\u2013Based Neuroimaging Studies","volume":"74","author":"Spencer","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1176\/appi.ajp.2012.11091421","article-title":"Cognitive Dysfunction and Anxious-Impulsive Personality Traits Are Endophenotypes for Drug Dependence","volume":"169","author":"Ersche","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11065-018-9384-6","article-title":"Neuropsychological Interventions for Decision-Making in Addiction: A Systematic Review","volume":"29","year":"2019","journal-title":"Neuropsychol. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuropharm.2013.06.013","article-title":"The Behavioral- and Neuro-Economic Process of Temporal Discounting: A Candidate Behavioral Marker of Addiction","volume":"76","author":"Bickel","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaac.2011.01.021","article-title":"Does ADHD Predict Substance-Use Disorders? A 10-Year Follow-up Study of Young Adults With ADHD","volume":"50","author":"Wilens","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_103","first-page":"14","article-title":"Comparing the Abuse Potential of Methylphenidate versus Other Stimulants: A Review of Available Evidence and Relevance to the ADHD Patient","volume":"64","author":"Kollins","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/add.12369","article-title":"Methylphenidate for Attention Deficit Hyperactivity Disorder and Drug Relapse in Criminal Offenders with Substance Dependence: A 24-week Randomized Placebo-controlled Trial","volume":"109","author":"Konstenius","year":"2014","journal-title":"Addiction"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/SAR.S440214","article-title":"Risk of Relapse Following Discharge from Non-Hospital Residential Opioid Use Disorder Treatment: A Systematic Review of Studies Published from 2018 to 2022","volume":"16","author":"Ware","year":"2025","journal-title":"Subst. Abus. Rehabil."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nn1578","article-title":"Is There a Common Molecular Pathway for Addiction?","volume":"8","author":"Nestler","year":"2005","journal-title":"Nat. Neurosci."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/8\/850\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:26:55Z","timestamp":1760034415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/15\/8\/850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":106,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["brainsci15080850"],"URL":"https:\/\/doi.org\/10.3390\/brainsci15080850","relation":{},"ISSN":["2076-3425"],"issn-type":[{"type":"electronic","value":"2076-3425"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}